Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK, and PD of GRT9906 in Healthy Volunteers
NCT03776110Phase 1Completed
- Sponsor
- Grünenthal GmbH
- Start
- Sep 2004
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of faxeladol in pain, sponsored by Grünenthal GmbH. Primary endpoint: Treatment Emergent Adverse Events. Started Sep 2004; status: completed.
02
Drugs
faxeladol
03
Conditions
pain
Beyond the preview
Go deeper on NCT03776110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03776110.